Worg Pharmaceuticals at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

Worg Pharmaceuticals takes part in 3 sessions at Festival of Biologics 2026 in Basel. Its program centres on start-up finance and investment, along with drug development for inflammatory and autoimmune diseases. It appears alongside Forty51 Ventures and VI Partners in an open exchange where attendees can put questions to investors.

OrganizationFestival of Biologics 2026 Attendance
Worg Pharmaceuticals
Hangzhou, China
Biotech
Develops immunotherapies for allergy and autoimmune diseases, with European headquarters at Switzerland Innovation Park Basel Area.
Panel
Wed Oct 14
17:10
Panel Discussion: Finance & Investment for Start Ups
Finance & Investment · with Pathways Preclinical Partners, Forty51 Ventures, VI Partners +1 more
Panel
Wed Oct 14
17:50
Extended Q&A - ask the investors
Finance & Investment · with Pathways Preclinical Partners, VI Partners, Forty51 Ventures +2 more
Chair
Thu Oct 15
08:55
Chair's Remarks
Disease Areas: Inflammation & Autoimmune

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Worg Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction